Skip to main content

Tonix Pharmaceuticals Holding Corp.

TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001430306

In the last 90 days, Tonix Pharmaceuticals Holding Corp. insiders filed 2 open-market purchases and 0 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Tonix Pharmaceuticals Holding Corp. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of TNXP: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders8988−1
Shares85.1M122.1M+37.0M (+43.5%)
Value$51.2M$43.7M−$7.43M (−14.5%)

New holders (11)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to TNXP in Q4 2021
InstitutionSharesValue% of portfolio
Anson Funds Management LP864,322$309.0K0.04%
Alps Advisors Inc548,866$196.0K0.00%
Susquehanna International Group, LLP126,077$45.0K0.00%
Credit Suisse AG62,236$22.0K0.00%
HRT Financial LP46,168$16.0K0.00%
Main Street Research LLC19,100$7.00K0.00%
Journey Strategic Wealth LLC10,000$4.00K0.00%
Beaird Harris Wealth Management, LLC2,500$1.00K0.00%
Meeder Asset Management Inc3$00.00%
Toronto Dominion Bank40$00.00%
CoreCap Advisors, LLC1––

Sold out (12)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of TNXP in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Qube Research & Technologies Ltd540,878$325.0K
Millennium Management LLC228,562$137.0K
Winton Group Ltd61,977$37.0K
Game Plan Financial Advisors, LLC27,216$16.0K
Gofen & Glossberg LLC25,000$15.0K
Two Sigma Investments, LP21,004$13.0K
HCR Wealth Advisors20,000$12.0K
Prentice Wealth Management LLC1,000$1.00K
FMR LLC599$0
Eaton Vance Management100$0
Ellevest, Inc.277$0
Firestone Capital Management100$0